Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Insulin, produced by the pancreas, regulates blood glucose by facilitating its entry into cells. Various types of insulin are ...

The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company ...

Insulin Aspart + Insulin Aspart Protamine is a combination of two medicines used to improve blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin ...

Arecor Presents Positive Data From Phase I Clinical Trial Of Ultra-Concentrated Ultra-Rapid Acting Insulin At278 In ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024 -Pre-clinical ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

So when the lights appear to flicker or she sees an aura — sure signs a migraine is imminent — she says she’ll reach for ...